276 related articles for article (PubMed ID: 26576938)
21. RNA aptamer against a cancer stem cell marker epithelial cell adhesion molecule.
Shigdar S; Lin J; Yu Y; Pastuovic M; Wei M; Duan W
Cancer Sci; 2011 May; 102(5):991-8. PubMed ID: 21281402
[TBL] [Abstract][Full Text] [Related]
22. High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.
Farnie G; Sotgia F; Lisanti MP
Oncotarget; 2015 Oct; 6(31):30472-86. PubMed ID: 26421710
[TBL] [Abstract][Full Text] [Related]
23. [Detection and clinical value of epithelial cellular adhesion molecule (EpCAM) mRNA positive circulating tumor cells in metastatic breast cancer].
Yan Y; Cheng JP; Di LJ; Song GH; Ren J
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 44(2):275-80. PubMed ID: 22517003
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-to-mesenchymal transition induced by TGF-β1 is mediated by AP1-dependent EpCAM expression in MCF-7 cells.
Gao J; Yan Q; Wang J; Liu S; Yang X
J Cell Physiol; 2015 Apr; 230(4):775-82. PubMed ID: 25205054
[TBL] [Abstract][Full Text] [Related]
25. Epithelial cell adhesion molecule-positive human hepatic neoplastic cells: development of combined hepatocellular-cholangiocarcinoma in mice.
Ogasawara S; Akiba J; Nakayama M; Nakashima O; Torimura T; Yano H
J Gastroenterol Hepatol; 2015 Feb; 30(2):413-20. PubMed ID: 25087473
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic significance of EpCAM expression in squamous cell carcinoma of the tongue and its possibility as a potential target for tongue cancer gene therapy.
Yanamoto S; Kawasaki G; Yoshitomi I; Iwamoto T; Hirata K; Mizuno A
Oral Oncol; 2007 Oct; 43(9):869-77. PubMed ID: 17207659
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells (CTCs) detected by triple-marker EpCAM, CK19, and hMAM RT-PCR and their relation to clinical outcome in metastatic breast cancer patients.
Zhao S; Yang H; Zhang M; Zhang D; Liu Y; Liu Y; Song Y; Zhang X; Li H; Ma W; Zhang Q
Cell Biochem Biophys; 2013 Mar; 65(2):263-73. PubMed ID: 22990361
[TBL] [Abstract][Full Text] [Related]
28. Oncostatin m renders epithelial cell adhesion molecule-positive liver cancer stem cells sensitive to 5-Fluorouracil by inducing hepatocytic differentiation.
Yamashita T; Honda M; Nio K; Nakamoto Y; Yamashita T; Takamura H; Tani T; Zen Y; Kaneko S
Cancer Res; 2010 Jun; 70(11):4687-97. PubMed ID: 20484035
[TBL] [Abstract][Full Text] [Related]
29. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
[TBL] [Abstract][Full Text] [Related]
30. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.
Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C
Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162
[TBL] [Abstract][Full Text] [Related]
31. Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles.
Tveito S; Andersen K; Kåresen R; Fodstad Ø
Breast Cancer Res; 2011 Aug; 13(4):R75. PubMed ID: 21816090
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological implications of EpCAM expression in adenocarcinoma of the lung.
Kim Y; Kim HS; Cui ZY; Lee HS; Ahn JS; Park CK; Park K; Ahn MJ
Anticancer Res; 2009 May; 29(5):1817-22. PubMed ID: 19443410
[TBL] [Abstract][Full Text] [Related]
33. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
34. EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
Kawashima R; Abei M; Fukuda K; Nakamura K; Murata T; Wakayama M; Seo E; Hasegawa N; Mizuguchi H; Obata Y; Hyodo I; Hamada H; Yokoyama KK
Int J Cancer; 2011 Sep; 129(5):1244-53. PubMed ID: 21710497
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
Sterzynska K; Kempisty B; Zawierucha P; Zabel M
Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
[TBL] [Abstract][Full Text] [Related]
36. By inhibiting Ras/Raf/ERK and MMP-9, knockdown of EpCAM inhibits breast cancer cell growth and metastasis.
Gao J; Liu X; Yang F; Liu T; Yan Q; Yang X
Oncotarget; 2015 Sep; 6(29):27187-98. PubMed ID: 26356670
[TBL] [Abstract][Full Text] [Related]
37. Granzyme B-based cytolytic fusion protein targeting EpCAM specifically kills triple negative breast cancer cells in vitro and inhibits tumor growth in a subcutaneous mouse tumor model.
Amoury M; Kolberg K; Pham AT; Hristodorov D; Mladenov R; Di Fiore S; Helfrich W; Kiessling F; Fischer R; Pardo A; Thepen T; Hussain AF; Nachreiner T; Barth S
Cancer Lett; 2016 Mar; 372(2):201-9. PubMed ID: 26806809
[TBL] [Abstract][Full Text] [Related]
38. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
39. Gene Knockdown by EpCAM Aptamer-siRNA Chimeras Suppresses Epithelial Breast Cancers and Their Tumor-Initiating Cells.
Gilboa-Geffen A; Hamar P; Le MT; Wheeler LA; Trifonova R; Petrocca F; Wittrup A; Lieberman J
Mol Cancer Ther; 2015 Oct; 14(10):2279-91. PubMed ID: 26264278
[TBL] [Abstract][Full Text] [Related]
40. EpCAM associates with endoplasmic reticulum aminopeptidase 2 (ERAP2) in breast cancer cells.
Gadalla SE; Öjemalm K; Vasquez PL; Nilsson I; Ericsson C; Zhao J; Nistér M
Biochem Biophys Res Commun; 2013 Sep; 439(2):203-8. PubMed ID: 23988446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
